Description: Smith & Nephew is a medical devices company engaged in the manufacture and sale of products in the orthopaedics, endoscopy, and wound management business sectors. Products include orthopaedic knee and hip implants, as well as trauma products, arthroscopy and advanced wound care products. These products include technologies such as OXINIUM, an alternate bearing material in orthopaedics, FAST-FIX and TWIN-FIX for knee and shoulder arthroscopic repair, and DERMAGRAFT, a tissue engineering product for treatment of diabetic foot ulcers.
Home Page: www.smith-nephew.com
Building 5
Watford,
WD18 8YE
United Kingdom
Phone:
44 1923 477 100
Officers
| Name | Title |
|---|---|
| Ms. Anne-Francoise Nesmes | CFO & Exec. Director |
| Dr. Deepak S. Nath Ph.D. | CEO & Director |
| Mr. Paul Connolly | Pres of Global Operations |
| Mr. Andrew Swift | VP of Investor Relations |
| Ms. Helen Barraclough | Group Gen. Counsel, Company Sec. & Director |
| Ms. Alison Parkes | Chief Compliance Officer |
| Mr. Joe Metzger | Sr. VP of Marketing Services & Communications |
| Ms. Elga Lohler | Chief HR Officer |
| Mr. Philip G. Cowdy | Chief Bus. Devel. & Corp. Affairs Officer |
| Mr. Bradley Cannon | Pres of Orthopaedics, Sports Medicine & ENT and Americas |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 15.5521 |
|---|---|
| Trailing PE: | 23.6842 |
| Price-to-Book MRQ: | 2.1223 |
| Price-to-Sales TTM: | 2.2585 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 18000 |